Chairman's
Statment

In this, my first Chairman’s statement since taking over from Ronnie Kells in February 2012, I would like to acknowledge his significant contribution to the Company during his time as Chairman.... read more

Chief
Executive’s
Review

2012 has been a highly significant year for United Drug in terms of strategic development and earnings momentum. The Group completed five acquisitions during the summer period.... read more

United Drug Map

Operating Profit*

€84.4m

2011: €76.8m

up arrow

+10%

operating bar chart

Profit before tax*

€75.8m

2011: €68.5m

up arrow

+11%

profit bar chart

Revenue

€1,830.2m

2011: €1,746.5m

up arrow

+5%

revenue bar chart

Dividend per share

9.04cent

2011: 8.66cent

up arrow

+4%

dividend bar chart

*before once-off acquisition costs, amortisation of intangible assets and exceptional item (2011).